APA (7th ed.) Citation

F, M., M, S., C, G., I, G., AL, F., R, A., & S, S. (2017). Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors. Expert opinion on therapeutic patents, 27(12), 1305. https://doi.org/10.1080/13543776.2017.1355908

Chicago Style (17th ed.) Citation

F, Musumeci, Sanna M, Greco C, Giacchello I, Fallacara AL, Amato R, and Schenone S. "Pyrrolo[2,3-d]pyrimidines Active as Btk Inhibitors." Expert Opinion on Therapeutic Patents 27, no. 12 (2017): 1305. https://doi.org/10.1080/13543776.2017.1355908.

MLA (9th ed.) Citation

F, Musumeci, et al. "Pyrrolo[2,3-d]pyrimidines Active as Btk Inhibitors." Expert Opinion on Therapeutic Patents, vol. 27, no. 12, 2017, p. 1305, https://doi.org/10.1080/13543776.2017.1355908.